Gilead Sciences (GILD) Current Deferred Tax Assets (2016)
Gilead Sciences (GILD) has disclosed Current Deferred Tax Assets for 8 consecutive years, with $857.0 million as the latest value for Q4 2016.
- For the quarter ending Q4 2016, Current Deferred Tax Assets rose 3.5% year-over-year to $857.0 million, compared with a TTM value of $857.0 million through Dec 2016, up 3.5%, and an annual FY2016 reading of $857.0 million, up 3.5% over the prior year.
- Current Deferred Tax Assets was $857.0 million for Q4 2016 at Gilead Sciences, up from $762.0 million in the prior quarter.
- Across five years, Current Deferred Tax Assets topped out at $894.0 million in Q3 2015 and bottomed at $193.9 million in Q1 2012.
- Average Current Deferred Tax Assets over 5 years is $501.1 million, with a median of $385.6 million recorded in 2014.
- The sharpest move saw Current Deferred Tax Assets tumbled 30.2% in 2012, then surged 132.46% in 2015.
- Year by year, Current Deferred Tax Assets stood at $262.6 million in 2012, then rose by 26.03% to $331.0 million in 2013, then soared by 53.47% to $508.0 million in 2014, then surged by 62.99% to $828.0 million in 2015, then rose by 3.5% to $857.0 million in 2016.
- Business Quant data shows Current Deferred Tax Assets for GILD at $857.0 million in Q4 2016, $762.0 million in Q3 2016, and $835.0 million in Q2 2016.